Phage-therapy best practices

Bacteriophages in Health and Disease

Volumn , Issue , 2012, Pages 256-272

  Abedon, Stephen T ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80055115377     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (51)

1. Abedon, S.T. (1990) Selection for lysis inhibition in bacteriophage. Journal of Theoretical Biology 146, 501-511.
2. Abedon, S.T. (1994) Lysis and the interaction between free phages and infected cells. In: Karam, J.D. (ed.) The Molecular Biology of Bacteriophage T4. ASM Press, Washington, DC, pp. 397-405.
3. Abedon, S.T. (1999) Bacteriophage T4 resistance to lysis-inhibition collapse. Genetical Research 74, 1-11.
4. Abedon, S.T. (2006) Phage ecology. In: Calendar, R. and Abedon, S.T. (eds) The Bacteriophages, 2nd edn. Oxford University Press, Oxford, UK, pp. 37-46.
5. Abedon, S.T. (2008a) Bacteriophage Ecology: Population Growth, Evolution, and Impact of Bacterial Viruses. Cambridge University Press, Cambridge, UK.
6. Abedon, S.T. (2008b) Ecology of viruses infecting bacteria. In: Mahy, B.W.J. and van Regenmortel, M.H.V. (eds) Encyclopedia of Virology, 3rd edn. Elsevier, Oxford, UK, pp. 71-77.
7. Abedon, S.T. (2009a) Bacteriophage intraspecific cooperation and defection. In: Adams, H.T. (ed.) Contemporary Trends in Bacteriophage Research. Nova Science Publishers, Hauppauge, NY, pp. 191-215.
8. Abedon, S.T. (2009b) Impact of phage properties on bacterial survival. In: Adams, H.T. (ed.) Contemporary Trends in Bacteriophage Research. Nova Science Publishers, Hauppauge, NY, pp. 217-235.
9. Abedon, S.T. (2009c) Kinetics of phage-mediated biocontrol of bacteria. Foodborne Pathogens and Disease 6, 807-815.
10. Abedon, S.T. (2009d) Phage evolution and ecology. Advances in Applied Microbiology 67, 1-45.
11. Abedon, S.T. (2010a) Bacteriophages and biofilms, In: Bailey, W.C. (ed.) Biofilms: Formation, Development and Properties. Nova Science Publishers, Hauppauge, NY, pp. 1-58.
12. Abedon, S.T. (2010b) The 'nuts and bolts' of phage therapy. Current Pharmaceutical Biotechnology 11, 1.
13. Abedon, S. (2011a) Phage therapy pharmacology: calculating phage dosing. Advances in Applied Microbiology 77, 1-40.
14. Abedon, S.T. (2011b) Bacteriophages and Biofilms: Ecology, Phage Therapy, Plaques. Nova Science Publishers, Hauppauge, NY.
15. Abedon, S.T. (2011c) Communication among phages, bacteria, and soil environments. In: Witzany, G. (ed.) Biocommunication of Soil Microorganisms. Springer, New York, NY, pp. 37-65.
16. Abedon, S.T. (2011d) Envisaging bacteria as phage targets. Bacteriophage 1, 228-230.
17. Abedon, S.T. (2011e) Lysis from without. Bacteriophage 1, 46-49.
18. Abedon, S.T. (in press) Bacteriophages as drugs: the pharmacology of phage therapy. In: Borysowski, J., Miêdzybrodzki, R. and Górski, A. (eds) Phage Therapy: Current Research and Applications. Caister Academic Press, Norfolk, UK.
19. Abedon, S.T. and Thomas-Abedon, C. (2010) Phage therapy pharmacology. Current Pharmaceutical Biotechnology 11, 28-47.
20. Abedon, S.T., Duffy, S. and Turner, P.E. (2009) Bacteriophage ecology. In: Schaecter, M. (ed.) Encyclopedia of Microbiology. Elsevier, Oxford, UK, pp. 42-57.
21. Abedon, S.T., Kuhl, S.J., Blasdel, B.G. and Kutter, E.M. (2011) Phage treatment of human infections. Bacteriophage 1, 66-85.
22. Balogh, B., Jones, J.B., Iriarte, F.B. and Momol, M.T. (2010) Phage therapy for plant disease control. Current Pharmaceutical Biotechnology 11, 48-57.
23. Boratynski, J., Syper, D., Weber-Dabrowska, B., Lusiak-Szelachowska, M., Pozniak, G. and Górski, A. (2004) Preparation of endotoxin-free bacteriophages. Cellular and Molecular Biology Letters 9, 253-259.
24. Bull, J.J. and Regoes, R.R. (2006) Pharmacodynamics of non-replicating viruses, bacteriocins and lysins. Proceedings of the Royal Society of London Series B Biological Sciences 273, 2703-2712.
25. Bull, J.J., Vimr, E.R. and Molineux, I.J. (2010) A tale of tails: sialidase is key to success in a model of phage therapy against K1-capsulated Escherichia coli. Virology 398, 79-86.
26. Chan, B.K. and Abedon, S.T. (2012a) Bacteriophage adaptation, with particular attention to issues of phage host range. In: Quiberoni, A. and Reinheimer, J. (eds) Bacteriophages in Dairy Processing. Nova Science Publishers, Hauppauge, NY, pp. 25-52.
27. Chan, B.K. and Abedon, S.T. (2012b) Phage therapy pharmacology: phage cocktails. Advances in Applied Microbiology 78, 1-23.
28. Curtright, A.J. and Abedon, S.T. (2011) Phage therapy: emergent properrty pharmacology. Journal of Bioanalysis and Biomedicine, S6.
29. Fogg, P.C., Allison, H.E., Saunders, J.R. and McCarthy, A.J. (2010) Bacteriophage lambda: a paradigm revisited. Journal of Virology 84, 6876-6879.
30. Gill, J.J. (2008) Modeling of bacteriophage therapy. In: Abedon, S.T. (ed.) Bacteriophage Ecology. Cambridge University Press, Cambridge, UK, pp. 439-464.
31. Gill, J.J. and Hyman, P. (2010) Phage choice, isolation and preparation for phage therapy. Current Pharmaceutical Biotechnology 11, 2-14.
32. Gill, J.J., Pacan, J.C., Carson, M.E., Leslie, K.E., Griffiths, M.W. and Sabour, P.M. (2006a) Efficacy and pharmacokinetics of bacteriophage therapy in treatment of subclinical Staphylococcus aureus mastitis in lactating dairy cattle. Antimicrobial Agents and Chemotherapy 50, 2912-2918.
33. Gill, J.J., Sabour, P.M., Leslie, K.E. and Griffiths, M.W. (2006b) Bovine whey proteins inhibit the interaction of Staphylococcus aureus and bacteriophage K. Journal of Applied Microbiology 101, 377-386.
34. Goodridge, L.D. (2008) Phages, bacteria, and food. In: Abedon, S.T. (ed.) Bacteriophage Ecology. Cambridge University Press, Cambridge, UK, pp. 302-331.
35. Goodridge, L.D. (2010) Designing phage therapeutics. Current Pharmaceutical Biotechnology 11, 15-27.
36. Hagens, S. and Loessner, M.J. (2010) Bacteriophage for biocontrol of foodborne pathogens: calculations and considerations. Current Pharmaceutical Biotechnology 11, 58-68.
37. Hyman, P. and Abedon, S.T. (2008) Phage ecology of bacterial pathogenesis. In: Abedon, S.T. (ed.) Bacteriophage Ecology. Cambridge University Press, Cambridge, UK, pp. 353-385.
38. Hyman, P. and Abedon, S.T. (2009) Practical methods for determining phage growth parameters. Methods in Molecular Biology 501, 175-202.
39. Hyman, P. and Abedon, S.T. (2010) Bacteriophage host range and bacterial resistance. Advances in Applied Microbiology 70, 217-248.
40. Kasman, L.M., Kasman, A., Westwater, C., Dolan, J., Schmidt, M.G., and Norris, J.S. (2002) Overcoming the phage replication threshold: a mathematical model with implications for phage therapy. Journal of Virology 76, 5557-5564.
41. Kutter, E., White, T., Kashlev, M., Uzan, M., McKinney, J., and Guttman, B. (1994) Effects on host genome structure and expression. In: Karam, J.D. (ed.) Molecular Biology of Bacteriophage T4. ASM Press, Washington, DC, pp. 357-368.
42. Kutter, E., de Vos, D., Gvasalia, G., Alavidze, Z., Gogokhia, L., Kuhl, S., and Abedon, S.T. (2010) Phage therapy in clinical practice: treatment of human infections. Current Pharmaceutical Biotechnology 11, 69-86.
43. Nasser, A.M., Glozman, R. and Nitzan, Y. (2002) Con tribution of microbial activity to virus reduction in saturated soil. Water Research 36, 2589-2595.
44. Payne, R.J.H. and Jansen, V.A.A. (2001) Understanding bacteriophage therapy as a density-dependent kinetic process. Journal of Theoretical Biology 208, 37-48.
45. Payne, R.J.H. and Jansen, V.A.A. (2003) Pharmacokinetic principles of bacteriophage therapy. Clinical Pharmacokinetics 42, 315-325.
46. Payne, R.J.H., Phil, D. and Jansen, V.A.A. (2000) Phage therapy: the peculiar kinetics of selfreplicating pharmaceuticals. Clinical Pharmacology and Therapeutics 68, 225-230.
47. Ramage, G., Culshaw, S., Jones, B. and Williams, C. (2010) Are we any closer to beating the biofilm: novel methods of biofilm control. Current Opinion in Infectious Diseases 23, 560-566.
48. Ryan, E.M., Gorman, S.P, Donnelly, R.F. and Gilmore, B.F. (2011) Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy. Journal of Pharmacy and Pharmacology 63, 1253-1264.
49. Smith, H.W. and Huggins, M.B. (1983) Effectiveness of phages in treating experimental Escherichia coli diarrhoea in calves, piglets and lambs. Journal of General Microbiology 129, 2659-2675.
50. Stent, G.S. (1963) Molecular Biology of Bacterial Viruses, W.H. Freeman and Co., San Francisco, CA.
51. Wilson, G.G., Young, K.K.Y., Edlin, G.J. and Konigsberg, W. (1979) High-frequency generalized transduction by bacteriophage T4. Nature 280, 80-82.